← Back to Analyst Consensus 
BEAM Buy
Beam Therapeutics Inc.
Current Price —
Implied Upside —
Analysts 22
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 15, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Oct 14, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Sep 9, 2026 | Wedbush | reiterate | Outperform → Outperform | — | 58% |
| Aug 25, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jul 8, 2026 | B of A Securities | reiterate | Buy → Buy | — | 53% |
| Jul 7, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 13, 2026 | Bernstein | maintain | Outperform → Outperform | — | 52% |
| Mar 26, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Feb 25, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | $26 | 55% |
| Feb 25, 2026 | Wedbush | maintain | Outperform → Outperform | $65 | 58% |
| Feb 20, 2026 | Canaccord Genuity | initiate | — → Buy | $74 | 48% |
| Jan 21, 2026 | Bernstein | maintain | Outperform → Outperform | $41 | 52% |
| Jan 7, 2026 | UBS | initiate | — → Neutral | $28 | 54% |
| Nov 24, 2025 | Evercore ISI Group | initiate | — → Outperform | $35 | 58% |
| Oct 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Oct 9, 2025 | JP Morgan | maintain | Overweight → Overweight | $46 | 54% |
| Sep 15, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Aug 6, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $21 | 53% |
| May 7, 2025 | Guggenheim | maintain | Buy → Buy | $55 | 52% |
| May 7, 2025 | Wells Fargo | maintain | Overweight → Overweight | $70 | 54% |
| May 7, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $25 | 53% |
| Apr 7, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Mar 28, 2025 | B of A Securities | upgrade | Neutral → Buy | $42 | 53% |
| Mar 12, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $0 | 50% |
| Mar 10, 2025 | Scotiabank | upgrade | Sector Perform → Sector Outperform | $40 | 55% |
| Mar 10, 2025 | Jones Trading | upgrade | Hold → Buy | $34 | 50% |
| Mar 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Mar 3, 2025 | Scotiabank | maintain | Sector Perform → Sector Perform | $25 | 55% |
| Feb 28, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Feb 27, 2025 | Guggenheim | reiterate | Buy → Buy | $78 | 52% |
| Feb 26, 2025 | RBC Capital | maintain | Sector Perform → Sector Perform | $26 | 55% |
| Feb 3, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Jan 29, 2025 | Cantor Fitzgerald | upgrade | Neutral → Overweight | $0 | 50% |
| Dec 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Nov 7, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Nov 6, 2024 | RBC Capital | maintain | Sector Perform → Sector Perform | $24 | 55% |
| Nov 6, 2024 | Leerink Partners | upgrade | Market Perform → Outperform | $39 | 51% |
| Oct 16, 2024 | Scotiabank | initiate | — → Sector Perform | $24 | 55% |
| Sep 19, 2024 | RBC Capital | reiterate | Sector Perform → Sector Perform | $27 | 55% |
| Sep 17, 2024 | Jones Trading | initiate | — → Hold | $0 | 50% |
| Sep 11, 2024 | Stifel | maintain | Buy → Buy | $69 | 53% |
| Aug 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $80 | 44% |
| Aug 7, 2024 | JP Morgan | maintain | Overweight → Overweight | $48 | 54% |
| Aug 7, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $31 | 53% |
| Aug 7, 2024 | RBC Capital | reiterate | Sector Perform → Sector Perform | $27 | 55% |
| Jul 23, 2024 | HC Wainwright & Co. | initiate | — → Buy | $80 | 44% |
| May 8, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $33 | 53% |
| Apr 23, 2024 | Wedbush | reiterate | Outperform → Outperform | $57 | 58% |
| Mar 27, 2024 | BMO Capital | maintain | Outperform → Outperform | $57 | 53% |
| Feb 28, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $42 | 53% |
Price Target Trend
Jun 13, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days